Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial (Q35762852)
Jump to navigation
Jump to search
scientific article published on 20 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial |
scientific article published on 20 April 2015 |
Statements
1 reference
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial (English)
1 reference
Angelo M De Marzo
1 reference
Elizabeth A Platz
1 reference
Corinne E Joshu
1 reference
Scott M Lippman
1 reference
Christopher M Heaphy
1 reference
Gaurav Gaonkar
1 reference
Sarah B Peskoe
1 reference
M Scott Lucia
1 reference
Phyllis J Goodman
1 reference
Ian M Thompson
1 reference
Alan K Meeker
1 reference
20 April 2015
1 reference
1 reference
75
1 reference
11
1 reference
1160-1166
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference